What impresses me is the clinical trial quality and the fairly low cost.
Only c.$1M AUD to complete Phase 2a when typical Phase 2 trials are 10x the cost to run.
We will have a comprehensive understanding of the mode of action and Dengue efficacy late 2022. Sit and wait investment.
What impresses me is the clinical trial quality and the fairly...
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.366M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13058 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 14085 | 1 |
View Market Depth
| Last trade - 16.12pm 19/07/2024 (20 minute delay) ? |
| ILA (ASX) Chart |
Day chart unavailable